Drug Controller General of India (DCGI)

COVID-19 in India: Phase 2 clinical trial of Sun Pharma’s AQCH commences

COVID-19 in India: Phase 2 clinical trial of Sun Pharma’s AQCH commences

Pharmaceutical company, Sun Pharma, has commenced Phase 2 clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatmen...Read More

Clinical trials for drug on CoVID-19 to start soon

Clinical trials for drug on CoVID-19 to start soon

Glenmark receives an approval from DCGI; country may get Corona medicine by September

Glenmark Pharma stocks rise nearly 9% on DCGI nod for clinical trials of COVID-19 tablets

Glenmark Pharma stocks rise nearly 9% on DCGI nod for clinical trials of COVID-19 tablets

Shares of Glenmark Pharmaceuticals on Thursday gained nearly 9 per cent after the company said it has received approval from DCGI to cond...Read More

Free Press Journal

www.freepressjournal.in